Pretreatment with alkylating agents predicts for tumor cell content and CD34(+) stem cell yield in leukapheresis products of patients with multiple myeloma

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kiel, Katja (VerfasserIn) , Goldschmidt, Hartmut (VerfasserIn)
Dokumenttyp: Kapitel/Artikel Konferenzschrift
Sprache:Englisch
Veröffentlicht: 1999
In: Autologous blood and marrow transplantation
Year: 1999, Pages: ?
Online-Zugang: Volltext
Verfasserangaben:Katja Kiel, Hartmut Goldschmidt

MARC

LEADER 00000caa a2200000 c 4500
001 1923412329
003 DE-627
005 20250717011008.0
007 tu
008 250422s1999 xx ||||| 00| ||eng c
035 |a (DE-627)1923412329 
035 |a (DE-599)KXP1923412329 
035 |a (OCoLC)1528044870 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kiel, Katja  |d 1967-  |e VerfasserIn  |0 (DE-588)120638312  |0 (DE-627)704889080  |0 (DE-576)292315856  |4 aut 
245 1 0 |a Pretreatment with alkylating agents predicts for tumor cell content and CD34(+) stem cell yield in leukapheresis products of patients with multiple myeloma  |c Katja Kiel, Hartmut Goldschmidt 
264 1 |c 1999 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
700 1 |a Goldschmidt, Hartmut  |d 1956-  |e VerfasserIn  |0 (DE-588)102258023X  |0 (DE-627)717003809  |0 (DE-576)365637386  |4 aut 
773 0 8 |i Enthalten in  |t Autologous blood and marrow transplantation  |d Charlottesville, Va. : Carden Jennings, 1999  |g (1999), Seite ?  |h XXXI, 755 S.  |w (DE-627)161082024X  |w (DE-576)085243817  |z 1891524046  |7 nnam  |a Pretreatment with alkylating agents predicts for tumor cell content and CD34(+) stem cell yield in leukapheresis products of patients with multiple myeloma 
773 1 8 |g year:1999  |g pages:?  |a Pretreatment with alkylating agents predicts for tumor cell content and CD34(+) stem cell yield in leukapheresis products of patients with multiple myeloma 
951 |a AR 
992 |a 20250422 
993 |a ConferencePaper 
994 |a 1999 
998 |g 102258023X  |a Goldschmidt, Hartmut  |m 102258023X:Goldschmidt, Hartmut  |d 910000  |d 910100  |e 910000PG102258023X  |e 910100PG102258023X  |k 0/910000/  |k 1/910000/910100/  |p 2  |y j 
998 |g 120638312  |a Kiel, Katja  |m 120638312:Kiel, Katja  |d 910000  |d 910100  |e 910000PK120638312  |e 910100PK120638312  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1923412329  |e 4708092229 
BIB |a Y 
JSO |a {"recId":"1923412329","relHost":[{"physDesc":[{"extent":"XXXI, 755 S.","noteIll":"graph. Darst."}],"origin":[{"dateIssuedDisp":"1999","dateIssuedKey":"1999","publisher":"Carden Jennings","publisherPlace":"Charlottesville, Va."}],"id":{"eki":["161082024X"],"isbn":["1891524046"]},"name":{"displayForm":["ed. by Karel A. Dicke ..."]},"part":{"year":"1999","pages":"?","text":"(1999), Seite ?"},"type":{"bibl":"edited-book"},"disp":"Pretreatment with alkylating agents predicts for tumor cell content and CD34(+) stem cell yield in leukapheresis products of patients with multiple myelomaAutologous blood and marrow transplantation","corporate":[{"role":"oth","display":"International Symposium of Blood and Marrow Transplantation (9, 1998, Arlington, Tex.)"}],"language":["eng"],"recId":"161082024X","title":[{"title_sort":"Autologous blood and marrow transplantation","title":"Autologous blood and marrow transplantation","subtitle":"proceedings of the ninth International Symposium [of Blood and Marrow Transplantation], Arlington, Texas"}],"person":[{"given":"Karel A.","family":"Dicke","role":"edt","display":"Dicke, Karel A.","roleDisplay":"Hrsg."}]}],"language":["eng"],"type":{"bibl":"chapter"},"name":{"displayForm":["Katja Kiel, Hartmut Goldschmidt"]},"person":[{"display":"Kiel, Katja","roleDisplay":"VerfasserIn","role":"aut","family":"Kiel","given":"Katja"},{"display":"Goldschmidt, Hartmut","roleDisplay":"VerfasserIn","role":"aut","family":"Goldschmidt","given":"Hartmut"}],"id":{"eki":["1923412329"]},"title":[{"title_sort":"Pretreatment with alkylating agents predicts for tumor cell content and CD34(+) stem cell yield in leukapheresis products of patients with multiple myeloma","title":"Pretreatment with alkylating agents predicts for tumor cell content and CD34(+) stem cell yield in leukapheresis products of patients with multiple myeloma"}],"origin":[{"dateIssuedKey":"1999","dateIssuedDisp":"1999"}]} 
SRT |a KIELKATJAGPRETREATME1999